Systemic lupus erythematosus (SLE) is the prototypic systemic autoimmune disease that has the potential to cause serious morbidity and early mortality and is responsible for tremendous costs to affected individuals and society. A striking feature of SLE is variation in health outcomes. In particular, substantial research documents ethnic disparities in SLE risk and severity. In spite of the magnitude of variation in SLE health outcomes, and the potential importance for patients, physicians and society, many questions remain about the underlying causes. For example, it remains unclear whether ethnic disparities in SLE outcomes reflect primarily individual, social, environmental or genetic variation in risk or interactions among these factors. Our lack of understanding is at least partially due to the challenges of assembling a sufficiently large and diverse cohort of SLE patients, measuring the full range of potentially important risk factors, and accurately assessing health outcomes. The current proposal represents a unique combination of clinical and investigative resources that has been developed to address this critically important issue. Specifically, we will: 1) determine the relative contributions of demographic, socioeconomic, psychosocial, behavioral and genetic factors to health outcomes in SLE;and 2) characterize changes in health outcomes over time and the contribution of these explanatory factors to temporal changes in outcome. A primary focus of this project will be the relationship of ethnicity to SLE outcomes, and in particular understanding the roles of genetics and other factors (e.g., socioeconomic, psychosocial, etc.) as mediators of ethnic disparities in outcome. Our study population will be approximately 1,000 SLE patients enrolled in the Lupus Outcome Study. We will use validated instruments to assess the following outcomes: general health status, disease activity and cumulative damage. A unique feature of the current proposal is the depth and breadth of potentially important explanatory factors that will be considered. In addition to traditional risk factors, these include novel measures of community characteristics obtained through """"""""geocoding"""""""" to small geographic areas and ancestry informative genetic markers. Due to the size and scope of this project, in conjunction with the rich resources and expertise of the MCRC, this project should substantially increase our understanding of health disparities in SLE and their underlying causes and guide efforts to remedy these disparities.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Comprehensive Center (P60)
Project #
5P60AR053308-05
Application #
8062281
Study Section
Special Emphasis Panel (ZAR1)
Project Start
Project End
2012-03-31
Budget Start
2010-04-01
Budget End
2012-03-31
Support Year
5
Fiscal Year
2010
Total Cost
$314,019
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Wysham, Katherine D; Shoback, Dolores M; Imboden Jr, John B et al. (2018) Association of High Anti-Cyclic Citrullinated Peptide Seropositivity and Lean Mass Index With Low Bone Mineral Density in Rheumatoid Arthritis. Arthritis Care Res (Hoboken) 70:961-969
Barton, Jennifer L; Hulen, Elizabeth; Schue, Allison et al. (2018) Experience and Context Shape Patient and Clinician Goals For Treatment of Rheumatoid Arthritis: A Qualitative Study. Arthritis Care Res (Hoboken) 70:1614-1620
Yelin, Edward; Yazdany, Jinoos; Trupin, Laura (2018) Relationship Between Poverty and Mortality in Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken) 70:1101-1106
Knight, Andrea M; Trupin, Laura; Katz, Patricia et al. (2018) Depression Risk in Young Adults With Juvenile- and Adult-Onset Lupus: Twelve Years of Followup. Arthritis Care Res (Hoboken) 70:475-480
Patel, Zubin; Lu, Xiaoming; Miller, Daniel et al. (2018) A plausibly causal functional lupus-associated risk variant in the STAT1-STAT4 locus. Hum Mol Genet :
Leonard, Dag; Svenungsson, Elisabet; Dahlqvist, Johanna et al. (2018) Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 77:1063-1069
Heshin-Bekenstein, Merav; Perl, Liat; Hersh, Aimee O et al. (2018) Final adult height of patients with childhood-onset systemic lupus erythematosus: a cross sectional analysis. Pediatr Rheumatol Online J 16:30
Jafri, Kashif; Ogdie, Alexis; Qasim, Atif et al. (2018) Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis. Clin Rheumatol 37:467-474
Mccormick, Natalie; Trupin, Laura; Yelin, Edward H et al. (2018) Socioeconomic Predictors of Incident Depression in Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken) 70:104-113
Lanata, Cristina M; Nititham, Joanne; Taylor, Kimberly E et al. (2018) Genetic contributions to lupus nephritis in a multi-ethnic cohort of systemic lupus erythematous patients. PLoS One 13:e0199003

Showing the most recent 10 out of 199 publications